Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study.
Mentrasti G, Cantini L, Vici P, D'Ostilio N, La Verde N, Chiari R, Paolucci V, Crocetti S, De Filippis C, Pecci F, Di Lisa FS, Traisci D, Cona MS, Nicolardi L, Pizzuti L, Gildetti S, Oldani S, Della Mora A, Bruno Rocchi ML, Berardi R. Mentrasti G, et al. Among authors: pizzuti l. Breast. 2022 Oct;65:164-171. doi: 10.1016/j.breast.2022.08.007. Epub 2022 Aug 18. Breast. 2022. PMID: 35998429 Free PMC article.
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Vici P, Colucci G, Giotta F, Sergi D, Filippelli G, Perri P, Botti C, Vizza E, Carpino A, Pizzuti L, Latorre A, Giannarelli D, Lopez M, Di Lauro L. Vici P, et al. Among authors: pizzuti l. J Exp Clin Cancer Res. 2011 Apr 12;30(1):39. doi: 10.1186/1756-9966-30-39. J Exp Clin Cancer Res. 2011. PMID: 21481280 Free PMC article. Clinical Trial.
A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.
Vici P, Giotta F, Di Lauro L, Sergi D, Vizza E, Mariani L, Latorre A, Pizzuti L, D'Amico C, Giannarelli D, Colucci G. Vici P, et al. Among authors: pizzuti l. Oncology. 2011;81(3-4):230-6. doi: 10.1159/000334432. Epub 2011 Nov 17. Oncology. 2011. PMID: 22094540 Clinical Trial.
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.
Sperati F, Vici P, Maugeri-Saccà M, Stranges S, Santesso N, Mariani L, Giordano A, Sergi D, Pizzuti L, Di Lauro L, Montella M, Crispo A, Mottolese M, Barba M. Sperati F, et al. Among authors: pizzuti l. PLoS One. 2013 Jul 22;8(7):e69269. doi: 10.1371/journal.pone.0069269. Print 2013. PLoS One. 2013. PMID: 23894438 Free PMC article. Review.
Hot flushes in women with breast cancer: state of the art and future perspectives.
Barba M, Pizzuti L, Sergi D, Maugeri-Saccà M, Vincenzoni C, Conti F, Tomao F, Vizza E, Di Lauro L, Di Filippo F, Carpano S, Mariani L, Vici P. Barba M, et al. Among authors: pizzuti l. Expert Rev Anticancer Ther. 2014 Feb;14(2):185-98. doi: 10.1586/14737140.2013.856271. Epub 2013 Dec 6. Expert Rev Anticancer Ther. 2014. PMID: 24313623 Review.
Immunologic treatments for precancerous lesions and uterine cervical cancer.
Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Cavallotti C, Paolini F, Venuti A. Vici P, et al. Among authors: pizzuti l. J Exp Clin Cancer Res. 2014 Mar 26;33(1):29. doi: 10.1186/1756-9966-33-29. J Exp Clin Cancer Res. 2014. PMID: 24667138 Free PMC article. Review.
147 results